SEI Investments’s Kyntra Bio KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,070
| Closed | -$39.3K | – | 2827 |
|
|
2025
Q1 | $39.3K | Hold |
5,070
| – | – | ﹤0.01% | 2695 |
|
|
2024
Q4 | $67.1K | Sell |
5,070
-3,916
| -44% | -$36.4K | ﹤0.01% | 2636 |
|
|
2024
Q3 | $89.7K | Buy |
8,986
+3,012
| +50% | +$45.5K | ﹤0.01% | 2567 |
|
|
2024
Q2 | $133K | Buy |
5,974
+1,658
| +38% | +$51.2K | ﹤0.01% | 2499 |
|
|
2024
Q1 | $254K | Hold |
4,316
| – | – | ﹤0.01% | 2370 |
|
|
2023
Q4 | $95.6K | Hold |
4,316
| – | – | ﹤0.01% | 2523 |
|
|
2023
Q3 | $93.1K | Sell |
4,316
-2,357
| -35% | -$92.6K | ﹤0.01% | 2523 |
|
|
2023
Q2 | $450K | Buy |
6,673
+334
| +5% | +$138K | ﹤0.01% | 2176 |
|
|
2023
Q1 | $2.96M | Buy |
6,339
+522
| +9% | +$276K | 0.01% | 1442 |
|
|
2022
Q4 | $2.33M | Buy |
5,817
+698
| +14% | +$267K | 0.01% | 1424 |
|
|
2022
Q3 | $1.67M | Hold |
5,119
| – | – | ﹤0.01% | 1618 |
|
|
2022
Q2 | $1.35M | Sell |
5,119
-7
| -0.1% | -$1.79K | ﹤0.01% | 1712 |
|
|
2022
Q1 | $1.54M | Buy |
5,126
+219
| +4% | +$76.3K | ﹤0.01% | 1638 |
|
|
2021
Q4 | $1.73M | Hold |
4,907
| – | – | ﹤0.01% | 1644 |
|
|
2021
Q3 | $1.25M | Sell |
4,907
-1,266
| -21% | -$449K | ﹤0.01% | 1696 |
|
|
2021
Q2 | $4.09M | Sell |
6,173
-2,185
| -26% | -$1.26M | 0.01% | 1187 |
|
|
2021
Q1 | $7.25M | Sell |
8,358
-1,053
| -11% | -$1.12M | 0.02% | 822 |
|
|
2020
Q4 | $8.73M | Buy |
9,411
+1,749
| +23% | +$1.84M | 0.02% | 704 |
|
|
2020
Q3 | $7.88M | Sell |
7,662
-599
| -7% | -$645K | 0.02% | 655 |
|
|
2020
Q2 | $8.37M | Buy |
8,261
+6,056
| +275% | +$5.62M | 0.03% | 619 |
|
|
2020
Q1 | $1.92M | Buy |
2,205
+799
| +57% | +$794K | 0.01% | 1160 |
|
|
2019
Q4 | $1.51M | Buy |
1,406
+197
| +16% | +$201K | ﹤0.01% | 1467 |
|
|
2019
Q3 | $1.12M | Sell |
1,209
-76
| -6% | -$83.5K | ﹤0.01% | 1560 |
|
|
2019
Q2 | $1.45M | Buy |
1,285
+291
| +29% | +$319K | ﹤0.01% | 1468 |
|
|
2019
Q1 | $1.35M | Sell |
994
-231
| -19% | -$313K | ﹤0.01% | 1469 |
|
|
2018
Q4 | $1.86M | Hold |
1,225
| – | – | 0.01% | 1321 |
|
|
2018
Q3 | $1.86M | Buy |
1,225
+114
| +10% | +$176K | 0.01% | 1289 |
|
|
2018
Q2 | $1.74M | Sell |
1,111
-46
| -4% | -$60K | 0.01% | 1381 |
|
|
2018
Q1 | $1.34M | Sell |
1,157
-42
| -4% | -$55.3K | 0.01% | 1348 |
|
|
2017
Q4 | $1.42M | Sell |
1,199
-293
| -20% | -$367K | ﹤0.01% | 1410 |
|
|
2017
Q3 | $2.01M | Buy |
1,492
+224
| +18% | +$236K | 0.01% | 1212 |
|
|
2017
Q2 | $1.02M | Hold |
1,268
| – | – | ﹤0.01% | 1421 |
|
|
2017
Q1 | $781K | Buy |
1,268
+196
| +18% | +$119K | ﹤0.01% | 1461 |
|
|
2016
Q4 | $574K | Buy |
1,072
+429
| +67% | +$214K | ﹤0.01% | 1536 |
|
|
2016
Q3 | $333K | Buy |
643
+192
| +43% | +$90.4K | ﹤0.01% | 1553 |
|
|
2016
Q2 | $185K | Hold |
451
| – | – | ﹤0.01% | 1575 |
|
|
2016
Q1 | $240K | Buy |
451
+21
| +5% | +$10.5K | ﹤0.01% | 1478 |
|
|
2015
Q4 | $327K | Sell |
430
-559
| -57% | -$371K | ﹤0.01% | 1440 |
|
|
2015
Q3 | $542K | Buy |
+989
| New | +$599K | 0.01% | 1264 |
|
Other funds holding KYNB
AC
CCM
SEI Investments's KYNB Position: Q2 2025 in Review
SEI Investments sold out of Kyntra Bio (KYNB) in Q2 2025, closing a stake of 5,070 shares — an estimated $39.3K sold.
SEI Investments first reported a position in KYNB in Q3 2015 and held it in 39 quarters. The position peaked at $8.73M in Q4 2020. 30 funds tracked by Wall St. Rank hold KYNB as of Q2 2025.
- SEI Investments reported no remaining Kyntra Bio position as of Q2 2025 after selling out during the quarter.
- SEI Investments sold 5,070 Kyntra Bio shares in Q2 2025, an estimated $39.3K.
- SEI Investments first reported a position in Kyntra Bio in Q3 2015 and held it in 39 quarters.
- SEI Investments's Kyntra Bio position peaked at $8.73M in Q4 2020.
- 30 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2025.
Based on SEI Investments's 13F filing for Q2 2025, filed 14 Aug 2025.